ID
35192
Beskrivning
Study ID: 111364 Clinical Study ID: 111364 Study Title: A 28-Day, Polysomnographic and subjective assessment of Vestipitant (15mg/day) for the treatment of Primary Insomnia in adult Outpatients Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00992160 Clinicaltrials.gov Links: https://clinicaltrials.gov/ct2/show/NCT00992160 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Vestipitant, Placebo Trade Name: N/A Study Indication: Primary Insomnia, Sleep Disorders The purpouse of this form is to record the results of the first vital sign measurement and should be filled out at visit 1. All vital signs should be taken in a sitting position
Länk
https://clinicaltrials.gov/ct2/show/NCT00992160
Nyckelord
Versioner (3)
- 2019-02-23 2019-02-23 -
- 2019-03-01 2019-03-01 -
- 2019-11-10 2019-11-10 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
23 februari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Polysomnographic Assessment of Vestipitant for the Treatment of Primary Insomnia NCT00992160
Similar models
Vital Signs
- StudyEvent: ODM
C2985720 (UMLS CUI [1,2])
C0442027 (UMLS CUI [1,2])